225 related articles for article (PubMed ID: 26343503)
21. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
[TBL] [Abstract][Full Text] [Related]
22. Generation of a human iPSC line from a Parkinson's disease patient with a novel CHCHD2 mutation (p.R145Q).
Chen X; Sun J; Wang T; Tang Q; Su L; Sun Y; Chen L; Seo H; Cheng T; Wang J; Song B
Stem Cell Res; 2024 Jun; 77():103419. PubMed ID: 38631182
[TBL] [Abstract][Full Text] [Related]
23. New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Puschmann A
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):66. PubMed ID: 28733970
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of CHCHD2 in Chinese patients with multiple system atrophy and amyotrophic lateral sclerosis.
Yang X; An R; Zhao Q; Zheng J; Tian S; Chen Y; Xu Y
J Neurol Sci; 2016 Sep; 368():389-91. PubMed ID: 27538669
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
[TBL] [Abstract][Full Text] [Related]
26. Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson's disease in a Chinese cohort.
Yang N; Zhao Y; Liu Z; Zhang R; He Y; Zhou Y; Xu Q; Sun Q; Yan X; Guo J; Tang B
Neurobiol Aging; 2019 Apr; 76():215.e1-215.e7. PubMed ID: 30598256
[TBL] [Abstract][Full Text] [Related]
27. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study.
Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N
Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704
[TBL] [Abstract][Full Text] [Related]
28. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
29. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
30. TMEM230 mutation analysis in Parkinson's disease in a Chinese population.
Yan W; Tang B; Zhou X; Lei L; Li K; Sun Q; Xu Q; Yan X; Guo J; Liu Z
Neurobiol Aging; 2017 Jan; 49():219.e1-219.e3. PubMed ID: 27814995
[TBL] [Abstract][Full Text] [Related]
31. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
[TBL] [Abstract][Full Text] [Related]
32. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
Ikeda A; Matsushima T; Daida K; Nakajima S; Conedera S; Li Y; Yoshino H; Oyama G; Funayama M; Nishioka K; Hattori N
Parkinsonism Relat Disord; 2017 Jan; 34():66-68. PubMed ID: 28341223
[No Abstract] [Full Text] [Related]
34. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
[TBL] [Abstract][Full Text] [Related]
35. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
36. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
[TBL] [Abstract][Full Text] [Related]
37. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
[TBL] [Abstract][Full Text] [Related]
38. The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population.
Zhao Y; Qin L; Pan H; Liu Z; Jiang L; He Y; Zeng Q; Zhou X; Zhou X; Zhou Y; Fang Z; Wang Z; Xiang Y; Yang H; Wang Y; Zhang K; Zhang R; He R; Zhou X; Zhou Z; Yang N; Liang D; Chen J; Zhang X; Zhou Y; Liu H; Deng P; Xu K; Xu K; Zhou C; Zhong J; Xu Q; Sun Q; Li B; Zhao G; Wang T; Chen L; Shang H; Liu W; Chan P; Xue Z; Wang Q; Guo L; Wang X; Xu C; Zhang Z; Chen T; Lei L; Zhang H; Wang C; Tan J; Yan X; Shen L; Jiang H; Zhang Z; Hu Z; Xia K; Yue Z; Li J; Guo J; Tang B
Brain; 2020 Jul; 143(7):2220-2234. PubMed ID: 32613234
[TBL] [Abstract][Full Text] [Related]
39. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
[TBL] [Abstract][Full Text] [Related]
40. Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation.
Jiang Z; Gu XJ; Su WM; Duan QQ; Lin JY; Cao B; Shang HF; Chen YP
Stem Cell Res; 2022 Oct; 64():102881. PubMed ID: 35944313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
